We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Roquefort Therapeutics Plc | LSE:ROQ | London | Ordinary Share | GB00BMDQ2T15 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.75 | 4.50 | 5.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 4.75 | 4.75 | 4.75 | 1,373 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Cmp Integrated Sys Design | 0 | -1.62M | -0.0125 | -3.80 | 6.13M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/4/2024 | 12:32 | ALNC |  IN BRIEF: Roquefort cancels fundraise after "unusual" stock movements |
| 05/4/2024 | 07:00 | UK RNS | Roquefort Therapeutics PLC Response to Share Price Movement |
| 11/3/2024 | 11:12 | ALNC | Roquefort celebrates "significant milestones" in cancer research |
| 11/3/2024 | 07:00 | UK RNS | Roquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNA |
| 06/2/2024 | 16:50 | ALNC | IN BRIEF: Roquefort hails further MK studies, licence talks continue |
| 06/2/2024 | 07:00 | UK RNS | Roquefort Therapeutics PLC Operations Update |
| 24/11/2023 | 07:00 | UKREG | Roquefort Therapeutics PLC Change of Auditor |
| 06/11/2023 | 12:01 | ALNC | Roquefort Therapeutics MK cell programme shows positive results |
| 06/11/2023 | 07:00 | UKREG | Roquefort Therapeutics PLC Significant Mesodermal Killer Cell Milestone |
| 27/9/2023 | 15:43 | ALNC | EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO |
1 Year Roquefort Therapeutics Chart |
Intraday Roquefort Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
